All Stories

  1. Assessment for residual disease after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
  2. Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease
  3. Liver abnormalities in pulmonary arterial hypertension
  4. Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension
  5. Abnormal levels of apolipoprotein A‐I in chronic thromboembolic pulmonary hypertension
  6. COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions
  7. Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension
  8. Sobre las recomendaciones del Ministerio de Salud para el tratamiento farmacológico de la COVID-19 en el Perú
  9. Lipids and ketones dominate metabolism in pulmonary arterial hypertension (PAH)
  10. Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
  11. Pulmonary thromboendarterectomy in the setting of a mediastinal venous malformation with a congenitally absent left subclavian vein
  12. Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension